Molecular Diagnostics Market Growth Rate, Overview, Future Trends, Product & Service, Test Type, Technology, Application, End-User and Global Forecast to 2027

The Molecular Diagnostics Market research survey offers an inclusive evaluation of the market and includes crucial future predictions, industry documentation, and market reality. This report reveals a comprehensive study of the collected information, with key players, sellers, and market dealers, along with key aspects influencing the market. The Molecular Diagnostics Market research study examines the international and regional breakdown of the industry and its uniqueness, market shares, trends, outlines, industry classifications, and the constantly transforming global market ecosystem. The Molecular Diagnostics Market research report provides profit predictions and geographic regions of the organization. The study's purposes are to present the product development in North America, China, Europe, South East Asia, Japan, and the rest of the world.

DOWNLOAD FREE SAMPLE REPORT: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4323886

Lists of Companies Profiled in the Molecular Diagnostics Market Report:

F. Hoffmann-La Roche Ltd. (Switzerland)
Hologic, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
PerkinElmer, Inc. (US)
Abbott Laboratories (US)
bioMérieux SA (France)
QIAGEN N.V. (Netherlands)
Myriad Genetics, Inc. (US)
Siemens Healthineers AG (Germany)
Danaher Corporation (US)
Illumina, Inc. (US)
Becton, Dickinson and Company (US)
Grifols, S.A. (Spain)
Quidel Corporation (US)
Agilent Technologies, Inc. (US)
DiaSorinS.p.a. (Italy)
Exact Sciences Corporation (US)
Genetic Signatures (Australia)
MDx Health (Belgium)
Biocartis NV (Belgium)
TBG Diagnostics Limited (Australia)
HTG Molecular Diagnostics, Inc. (US)
Vela Diagnostics (Singapore)
Amoy Diagnostics Co., Ltd. (China)
ELITechGroup (France)
Molbio Diagnostics Pvt. Ltd. (India)
Savyon Diagnostics (Israel)
Abacus Diagnostica Oy (Finland)
geneOmbio Technologies Pvt. Ltd. (India)

The global molecular diagnostics market is projected to reach USD 30.2 billion by 2027 from USD 23.2 billion in 2022, at a CAGR of 5.4% during the forecast period.

Market growth is driven by factors such as the increasing use of PoC diagnostic tests, the rising funding for R&D in molecular diagnostics, the increasing prevalence of infectious diseases and cancer. On the other hand, an unfavorable reimbursement scenario and the high cost of instruments may restrain the growth of this market to a certain extent.

"The DNA sequencing & NGS segment accounted for the highest growth rate in the molecular diagnostics market, by technology, during the forecast period"

The molecular diagnostics market is segmented into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), in situ hybridization (ISH), DNA sequencing & next-generation sequencing (NGS), DNA microarrays, and other technologies. The DNA sequencing & NGS segment is expected to register the highest growth rate during the forecast period. Factors such as the growing focus of key market players on developing and launching diagnostic NGS kits and panels, increasing applications of sequencing in genomics research, and the increasing focus on molecular-targeted drugs/therapies (personalized medicine) contribute to the growth of this segment.

"Oncology testing segment accounted for the highest CAGR"

Based on applications, the molecular diagnostics market is segmented into infectious disease diagnostics, oncology testing, genetic testing, and other applications. The oncology testing segment is expected to register the highest CAGR during the forecast period. Technological advancements, the increasing prevalence of cancer, and the growing focus on personalized medicine contribute to the growth of this market segment.

"The Asia Pacific market is expected to grow at the highest CAGR during the forecast period"

The global molecular diagnostics market is segmented into five regions - North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to witness the highest growth in the molecular diagnostics market during the forecast period. This can be attributed tofactors such as continuously rising healthcare expenditures, government efforts to increase awareness about the early detection of diseases and regular health check-ups,an increasing number of hospitals and clinical diagnostic laboratories in India and China, and strengthening research bases for diagnostic procedures across India, China, and Japan. Furthermore, supportive government regulations will further aid the growth of this market during the forecast period.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa - 4%

Research Coverage:

This report provides a detailed picture of the global molecular diagnostics market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, test type, technology, application, end user,and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall molecular diagnostics market and its sub segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Ask Report Queries: https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=4323886

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions And Exclusions Of The Study
1.3 Markets Covered
1.3.1 Molecular Diagnostics Market
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary Of Changes

2 Research Methodology
2.1 Research Data
2.2 Research Approach
Figure 1 Molecular Diagnostics Market: Research Design Methodology
2.2.1 Secondary Data
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Data
2.2.2.1 Primary Sources
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Industry Insights
2.2.2.4 Breakdown Of Primary Interviews
Figure 2 Breakdown Of Primary Interviews: Supply-Side And Demand-Side Participants
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.1.1 Approach 1: Company Revenue Estimation Approach
Figure 4 Bottom-Up Approach: Company Revenue Estimation Approach
2.3.1.2 Approach 2: Presentations Of Companies And Primary Interviews
2.3.1.3 Growth Forecast
2.3.1.4 Cagr Projections
Figure 5 Cagr Projections: Supply-Side Analysis
2.3.2 Top-Down Approach
Figure 6 Molecular Diagnostics Market: Top-Down Approach
2.4 Market Breakdown And Data Triangulation
Figure 7 Data Triangulation Methodology
2.5 Market Share Analysis
2.6 Assumptions For The Study
2.7 Limitations
2.8 Growth Rate Assumptions
2.9 Risk Assessment
2.9.1 Risk Assessment: Molecular Diagnostics Market

3 Executive Summary
Figure 8 Molecular Diagnostics Market, By Product & Service, 2022 Vs. 2027 (Usd Million)
Figure 9 Molecular Diagnostics Market, By Test Type, 2022 Vs. 2027 (Usd Million)
Figure 10 Molecular Diagnostics Market, By Technology, 2022 Vs. 2027 (Usd Million)
Figure 11 Molecular Diagnostics Market, By Application, 2022 Vs. 2027 (Usd Million)
Figure 12 Molecular Diagnostics Market, By End User, 2022 Vs. 2027 (Usd Million)
Figure 13 Molecular Diagnostics Market, By Region, 2022 Vs. 2027 (Usd Million)

4 Premium Insights
4.1 Molecular Diagnostics Market Overview
Figure 14 Increasing Prevalence Of Infectious Diseases And Cancer Is Expected To Support Market Growth During The Forecast Period
4.2 Molecular Diagnostics Market, By Product & Service, 2022 Vs. 2027
Figure 15 Reagents & Kits Will Continue To Dominate The Market In 2026
4.3 Molecular Diagnostics Market, By Test Type, 2022 Vs. 2027
Figure 16 The Lab Tests Segment Will Continue To Dominate The Market In 2026
4.4 Molecular Diagnostics Market, By Technology, 2022 Vs. 2027
Figure 17 The Pcr Segment Is Expected To Dominate The Market During The Forecast Period
4.5 Molecular Diagnostics Market, By Application, 2022 Vs. 2027
Figure 18 The Infectious Disease Diagnostics Segment To Continue To Dominate The Market In 2026
4.6 Molecular Diagnostics Market, By End User, 2022 Vs. 2027
Figure 19 The Diagnostic Laboratories Segment To Continue To Dominate The Market In 2026
4.7 Molecular Diagnostics Market: Geographic Growth Opportunities
Figure 20 Asia Pacific To Register The Highest Growth Rate In The Molecular Diagnostics Market During The Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 21 Molecular Diagnostics Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Increasing Prevalence Of Infectious Diseases And Cancer
Table 1 Estimated Number Of New Cancer Cases Globally, By Type Of Cancer, 2020 Vs. 2025
Table 2 Global Cancer Incidence, By Region, 2020 Vs. 2025
5.2.1.2 Rising Focus On R&D And Growing Funding In Molecular Diagnostics
5.2.1.3 Growing Awareness Of Early Disease Diagnosis In Developing Countries
5.2.1.4 Rising Technological Advancements In Molecular Diagnostics
5.2.1.5 Increasing Use Of Poc Diagnostic Tests
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursement Scenario
5.2.2.2 High Cost Of Instruments
5.2.3 Opportunities
5.2.3.1 Growing Significance Of Companion Diagnostics
5.2.3.2 Growth Opportunities In Emerging Countries
5.2.4 Challenges
5.2.4.1 Changing Regulatory Landscape
5.2.4.2 Operational Barriers
5.2.4.3 Introduction Of Alternative Technologies
5.2.5 Impact Of Covid-19 On The Molecular Diagnostics Market
5.3 Pricing Analysis
Table 3 Average Selling Price Of Molecular Diagnostic Products (2022)
5.4 Patent Analysis
Figure 22 List Of Major Patents For Isothermal Nucleic Acid Amplification Technologies
5.4.1 List Of Major Patents
5.5 Value Chain Analysis
Figure 23 Value Chain Analysis Of The Molecular Diagnostics Market: Major Value Is Added During The Manufacturing And Assembly Phases
5.6 Supply Chain Analysis
Figure 24 Molecular Diagnostics Market: Supply Chain Analysis
5.7 Ecosystem/Market Map
Figure 25 Molecular Diagnostics Market: Ecosystem/Market Map
5.7.1 Molecular Diagnostics Market: Role In Ecosystem
5.8 Porter's Five Forces Analysis
Table 4 Molecular Diagnostics Market: Porter's Five Forces Analysis
5.8.1 Threat From New Entrants
5.8.2 Threat From Substitutes
5.8.3 Bargaining Power Of Buyers
5.8.4 Bargaining Power Of Suppliers
5.8.5 Degree Of Competition
5.9 Regulatory Landscape
Table 5 North America: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 6 Asia Pacific: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 7 Latin America: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 8 Rest Of The World: List Of Regulatory Bodies, Government Agencies, And Other Organizations
5.9.1 North America
5.9.1.1 Us
5.9.1.2 Canada
5.9.2 Europe
Table 9 Europe: Classification Of Devices
5.9.3 Asia Pacific
5.9.3.1 China
5.9.3.2 Japan
5.9.3.3 India
5.9.4 Latin America
5.9.4.1 Brazil
5.9.4.2 Mexico
5.9.5 Middle East
5.9.6 Africa
5.10 Trade Analysis
5.10.1 Trade Analysis For Diagnostic And Laboratory Reagents
5.10.1.1 Import Data For Diagnostic And Laboratory Reagents, By Country, 2017-2021 (Usd Million)
5.10.1.2 Export Data For Diagnostic And Laboratory Reagents, By Country, 2017-2021 (Usd Million)
5.11 Technology Analysis
5.12 Key Conferences & Events In 2022-2023
Table 10 Molecular Diagnostics Market: Detailed List Of Conferences & Events
5.13 Trends/Disruptions Impacting Customers' Businesses
5.13.1 Revenue Sources Are Shifting Towards Technology-Based Solutions Due To The Covid-19 Pandemic
Figure 26 Revenue Shift In The Molecular Diagnostics Market
5.14 Key Stakeholders & Buying Criteria
5.14.1 Key Stakeholders In The Buying Process, By End User
Figure 27 Influence Of Stakeholders In The Buying Process, By End User
Table 11 Influence Of Stakeholders In The Buying Process, By End User (%)
5.14.2 Buying Criteria
Figure 28 Key Buying Criteria, By End User
Table 12 Key Buying Criteria, By End User
5.15 Case Studies
Figure 29 Case Study: Market Assessment And Consumer Buying Behavior In India

6 Molecular Diagnostics Market, By Product & Service
6.1 Introduction
Table 13 Molecular Diagnostics Market, By Product & Service, 2020-2027 (Usd Million)
Table 14 Prices Of Molecular Diagnostic Products (2021)
6.2 Reagents & Kits
6.2.1 Recurrent Purchases Of Reagents & Kits-A Key Factor Propelling Market Growth
Table 15 Molecular Diagnostic Reagents & Kits Market, By Region, 2020-2027 (Usd Million)
6.3 Instruments
6.3.1 Increasing Need For Faster & More Accurate Test Results To Boost The Demand For Molecular Diagnostic Instruments
Table 16 Key Instruments Available In The Market
Table 17 Molecular Diagnostic Instruments Market, By Region, 2020-2027 (Usd Million)
6.4 Services & Software
6.4.1 Growing Uptake Of Advanced Instruments In The Molecular Diagnostics Market To Drive Growth In This Market Segment
Table 18 Molecular Diagnostic Services & Software Market, By Region, 2020-2027 (Usd Million)

7 Molecular Diagnostics Market, By Test Type
7.1 Introduction
Table 19 Molecular Diagnostics Market, By Test Type, 2020-2027 (Usd Million)
7.2 Lab Tests
7.2.1 High Burden Of Covid-19 To Drive Market Growth
Table 20 Molecular Diagnostics Market For Lab Tests, By Region, 2020-2027 (Usd Million)
7.3 Poc Tests
7.3.1 Increasing Adoption Of Poc Technologies To Drive Segmental Growth In The Coming Years
Table 21 Molecular Diagnostics Market For Poc Tests, By Region, 2020-2027 (Usd Million)

8 Molecular Diagnostics Market, By Technology
8.1 Introduction
8.1.1 Primary Notes
8.1.1.1 Key Industry Insights
Table 22 Molecular Diagnostics Market, By Technology, 2020-2027 (Usd Million)
8.2 Polymerase Chain Reaction (Pcr)
8.2.1 Growing Use Of Pcr In Proteomics And Genomics Makes This The Largest Market Segment
Table 23 Molecular Diagnostics Market For Polymerase Chain Reaction, By Region, 2020-2027 (Usd Million)
8.3 Isothermal Nucleic Acid Amplification Technology (Inaat)
8.3.1 Cost Benefits Of Inaat To Drive Market Growth
Table 24 Molecular Diagnostics Market For Isothermal Nucleic Acid Amplification Technology, By Region, 2020-2027 (Usd Million)
8.4 Dna Sequencing & Next-Generation Sequencing
8.4.1 Increasing Use Of Ngs In Cancer Diagnosis To Fuel Growth In This Market Segment
Table 25 Molecular Diagnostics Market For Dna Sequencing & Next-Generation Sequencing, By Region, 2020-2027 (Usd Million)
8.5 In Situ Hybridization (Ish)
8.5.1 Rising Prevalence Of Cancer And Genetic Disorders- A Key Factor Driving Growth
Table 26 Molecular Diagnostics Market For In Situ Hybridization, By Region, 2020-2027 (Usd Million)
8.6 Dna Microarrays
8.6.1 Introduction Of Dna Microarrays Has Accelerated Gene Expression And Disease Diagnosis
Table 27 Molecular Diagnostics Market For Dna Microarrays, By Region, 2020-2027 (Usd Million)
8.7 Other Technologies
Table 28 Molecular Diagnostics Market For Other Technologies, By Region, 2020-2027 (Usd Million)

9 Molecular Diagnostics Market, By Application

Direct Purchase of Molecular Diagnostics Market Research Report at: https://www.reportsnreports.com/purchase.aspx?name=4323886

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.